Antigen properties shape antigen‐specific T cell phenotype.[259, 260, 261] Thus, antigen‐based cancer vaccines may be utilized to induce stem‐like T cells to enhance PD‐1/PD‐L1 blockade response. The gene discussed is CD274; the disease is cancer.